Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Tilorona")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 10 of 10

  • Page / 1
Export

Selection :

  • and

A7 nicotinic acetylcholine receptor agonist properties of tilorone and related tricyclic analoguesBRIGGS, C. A; SCHRIMPF, M. R; BUNNELLE, W. H et al.British journal of pharmacology. 2008, Vol 153, Num 5, pp 1054-1061, issn 0007-1188, 8 p.Article

SAR of α7 nicotinic receptor agonists derived from tilorone: Exploration of a novel nicotinic pharmacophoreSCHRIMPF, Michael R; SIPPY, Kevin B; MEYER, Michael D et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 4, pp 1633-1638, issn 0960-894X, 6 p.Article

Effects of the immunomodulator tilorone on the acetylation of 2-aminofluorene and DNA-2-aminofluorene adducts in the ratsCHUNG, J.-G; CHANG, H.-L; YEH, C.-C et al.Anticancer research. 2000, Vol 20, Num 1A, pp 467-473, issn 0250-7005Article

Biocatalysed synthesis of β-O-glucosides from 9-fluorenon-2-carbohydroxyesters. Part 3 IFN-inducing and anti-HSV-2 propertiesALCARO, Stefano; ARENA, Adriana; DI BELLA, Rosaria et al.Bioorganic & medicinal chemistry. 2005, Vol 13, Num 10, pp 3371-3378, issn 0968-0896, 8 p.Article

Lysosomal glycosaminoglycan storage as induced by dicationic amphiphilic drugs : Investigation into the mechanisms underlying the slow reversibilityBISPINCK, F; FISCHER, J; LÜLLMANN-RAUCH, R et al.Toxicology (Amsterdam). 1998, Vol 128, Num 2, pp 91-100, issn 0300-483XArticle

Time course of the tilorone-induced lysosomal accumulation of sulphated glycosaminoglycans in cultured fibroblastsBISPINCK, F; FISCHER, J; LÜLLMANN-RAUCH, R et al.Experimental and toxicologic pathology (Print). 1998, Vol 50, Num 4-6, pp 411-415, issn 0940-2993Article

Simultaneous quantification of tiloronoxim and tilorone in human urine by liquid chromatography-tandem mass spectrometryXIANHUA ZHANG; LI YANG; SUODI ZHAI et al.Journal of chromatography. B. 2008, Vol 875, Num 2, pp 349-357, issn 1570-0232, 9 p.Article

Design and synthesis of DNA-intercalating 9-fluoren-β-O-glycosides as potential IFN-inducers, and antiviral and cytostatic agentsALCARO, S; ARENA, A; NERI, S et al.Bioorganic & medicinal chemistry. 2004, Vol 12, Num 7, pp 1781-1791, issn 0968-0896, 11 p.Article

Tiloron-induzierte funktionelle Veränderungen der Rattenretina = Tiloron-induced functional changes in the rat retinaBREDEHORN, T; DUNCKER, G. I. W.Klinische Monatsblätter für Augenheilkunde. 2000, Vol 216, Num 4, pp 219-222, issn 0023-2165Article

Study of anti-HIV activity of yeast RNA-tilorone molecular complexKARPOV, A. V; ANTONENKO, S. V; BARBASHEVA, Y. V et al.Voprosy virusologii. 1997, Vol 42, Num 1, pp 17-19, issn 0507-4088Article

  • Page / 1